Skip to main navigation Skip to search Skip to main content

Adalimumab does not cause weight gain in patients with psoriasis in the first year of treatment

Original languageEnglish
JournalClinical and Experimental Dermatology
Volume48
Issue number10
Pages (from-to)1169-1171
Number of pages3
ISSN0307-6938
DOIs
Publication statusPublished - 19 Sept 2023

Keywords

  • Adalimumab/adverse effects
  • Antibodies, Monoclonal, Humanized/adverse effects
  • Humans
  • Psoriasis/chemically induced
  • Severity of Illness Index
  • Treatment Outcome
  • Weight Gain

Cite this